(Q38305006)

2 September 2017

Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins (English)

1 reference

2 September 2017

0 references

1 reference

1 reference

1

1 reference

2 September 2017

Anita Mangia

2

0 references

Maria Kavallaris

13

object named as

Maria Kavallaris

1 reference

2 September 2017

Rosanna Lacalamita

3

1 reference

2 September 2017

Antonia Bellizzi

4

1 reference

2 September 2017

Vita Fedele

5

1 reference

2 September 2017

Annalisa Chiriatti

6

1 reference

2 September 2017

Christopher Thomssen

7

1 reference

2 September 2017

Nancy Kendzierski

8

1 reference

2 September 2017

Agnese Latorre

9

1 reference

2 September 2017

Vito Lorusso

10

1 reference

2 September 2017

Francesco Schittulli

11

1 reference

2 September 2017

Francesco Zito

12

1 reference

2 September 2017

Angelo Paradiso

14

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

International Journal of Cancer

2 September 2017

1 reference

2 September 2017

120

1 reference

2 September 2017

2078-2085

1 reference

2 September 2017

10

1 reference

A lineage-restricted and divergent beta-tubulin isoform is essential for the biogenesis, structure and function of blood platelets

2 September 2017

1 reference

Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization

21 January 2018

1 reference

Structure of the alpha beta tubulin dimer by electron crystallography

21 January 2018

1 reference

Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions

21 January 2018

1 reference

Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells

21 January 2018

1 reference

Mutational analysis of the class I beta-tubulin gene in human breast cancer

21 January 2018

1 reference

Mutation of the class I beta-tubulin gene does not predict response to paclitaxel for breast cancer.

21 January 2018

1 reference

Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry.

21 January 2018

1 reference

Comparison of beta-tubulin mRNA and protein levels in 12 human cancer cell lines

21 January 2018

1 reference

Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression.

21 January 2018

1 reference

Differentiation of human colon cancer cells changes the expression of beta-tubulin isotypes and MAPs

21 January 2018

1 reference

Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol

21 January 2018

1 reference

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

21 January 2018

1 reference

Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells

21 January 2018

1 reference

Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol

21 January 2018

1 reference

Mutations at leucine 215 of beta-tubulin affect paclitaxel sensitivity by two distinct mechanisms

21 January 2018

1 reference

Molecular and functional characteristics of erbB2 in normal and cancer breast cells

21 January 2018

1 reference

Mutational analysis of the beta-tubulin gene in lung cancer

21 January 2018

1 reference

Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics

21 January 2018

1 reference

Altered expression of M beta 2, the class II beta-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance

21 January 2018

1 reference

Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study

21 January 2018

1 reference

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

21 January 2018

1 reference

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

21 January 2018

1 reference

A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923.

21 January 2018

1 reference

Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer

21 January 2018

1 reference

p53-independent apoptosis induced by paclitaxel through an indirect mechanism

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.22557

1 reference

2 September 2017

1 reference